Public Release: 

Elsevier launches JACC: Basic to Translational Science

A new open access publication joins the family of focused JACC journals

Elsevier Health Sciences

New York, NY, March 16, 2016 - Elsevier, a world-leading provider of scientific, technical, and medical information products and services, is pleased to announce publication of the inaugural issue of JACC: Basic to Translational Science, a new open access peer-reviewed journal. Published on behalf of the American College of Cardiology (ACC), this new bi-monthly journal focuses on the critical interface between laboratory and clinical science.

Led by Editor-in-Chief Douglas L. Mann, MD, FACC, and an eminent editorial board, JACC: Basic to Translational Science is designed to be both a forum and a learning center for cardiovascular investigators in academia and industry, patients and families impacted by heart disease, the National Heart Blood and Lung Institute and the US Food and Drug Administration to help advance translational cardiovascular medicine. It serves as a platform for accelerating the translation of new scientific discoveries into new therapies that improve clinical outcomes for patients afflicted with or at risk for cardiovascular disease.

"We find two compelling reasons to launch this journal in collaboration with Elsevier and ACC. The first is to create a true scientific literary home for cardiovascular 'translationalists' who wish to publish research that stands firmly at the crossroads of basic and clinical research, that presents new ideas and potentially leads to new therapies," explained Dr. Mann. "The second, and perhaps more compelling, is the unprecedented opportunity today to develop novel cardiovascular drugs and devices. The explosion of 'omic' technologies, bioinformatics, in silico structure modeling, high throughput screening, and novel clinical designs, and the willingness of Congress to advance new clinical therapies have converged to offer an extremely opportune time for investigators to focus their efforts on developing new cardiovascular therapies."

Manuscripts are currently being accepted at Thematic areas of interest include pre-clinical research; clinical trials; personalized medicine; novel drugs, devices and biologics; proteomics, genomics and metabolomics; and early-phase clinical trial methodology.

"It is extremely gratifying to have the opportunity to launch such a high quality and precisely targeted journal. We recognize the vital role that JACC: Basic to Translational Science publication will play in facilitating the translation of research initiatives in cardiovascular medicine, with the potential to lead to truly groundbreaking advancements in patient care," commented Nancy Axelrod, Executive Publisher at Elsevier. "As publishers of ACC's official journals for more than 30 years, including the Journal of the American College of Cardiology, we are confident of its success."


Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.